Cochlin-tomoprotein test and hearing outcomes in surgically treated true idiopathic perilymph fistula

Manabu Komori1, Yutaka Yamamoto1, Yuichiro Yaguchi1

  • 1a Department of Otorhinolaryngology , The Jikei University School of Medicine , Tokyo , Japan ;

Insights

Early surgery for spontaneous perilymph fistula (sPLF) improves hearing outcomes. The cochlin-tomoprotein (CTP) test aids in diagnosing sPLF, with about half of clinically diagnosed cases being CTP-positive.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Audiology

Background:

  • Idiopathic spontaneous perilymph fistula (sPLF) diagnosis is challenging.
  • sPLF is suspected in cases of acute sensorineural hearing loss with vertigo, progressing despite steroid treatment.

Purpose of the Study:

  • Evaluate cochlin-tomoprotein (CTP) test utility in sPLF diagnosis.
  • Assess surgical outcomes in patients with sPLF, correlating with CTP test results.

Main Methods:

  • Retrospective study of 23 patients diagnosed with sPLF undergoing exploratory tympanotomy.
  • Analysis of CTP test results and post-operative hearing outcomes.

Main Results:

  • CTP test was positive in 11 out of 23 patients.
  • CTP-positive patients showed significant hearing improvement post-surgery (mean 66.5 dB pre-op to 42.3 dB post-op).
  • Surgery within 7 days of onset yielded significantly better hearing recovery than later intervention.

Conclusions:

  • Approximately 50% of clinically diagnosed sPLF cases were confirmed as CTP-positive.
  • Early surgical intervention (within 7 days) is crucial for improving therapeutic response in hearing loss associated with sPLF.
Abstract

Related Concept Videos